Table 5.
Key Areas for Future MBL Research
I. Identification of epidemiologic factors associated with development of MBL
|
II. Clinical outcome of low count MBL
|
III. Identification of clinical and biologic parameters that allow optimal classification of patients with small B-cell clones (MBL vs. CLL vs. SLL)
|
IV. Identification of the biologic events related to progression of MBL to CLL or other NHL
|
| V. Studies exploring a potential tissue equivalent of MBL |